Working… Menu

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. (CALAVI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04346199
Recruitment Status : Completed
First Posted : April 15, 2020
Last Update Posted : February 2, 2021
Acerta Pharma BV
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 17, 2020
Actual Study Completion Date : November 17, 2020